Ranked GEO Datasets

Active GEO index contains 44678 ranked datasets; organism mixed: Homo sapiens (32691), Mus musculus (11987); assay type mixed: microarray (24292), bulk RNA-seq (19023), other assay type (1363). Rankings use the Patient tissue tumor-vs-normal intent with transparent suitability, metadata quality, and warning rules.

Gene snapshot Projects Saved searches CSV Markdown
50 shown of 159 matching datasets Scoring intent-aware-scoring-v19 Batch d7cf15dd0c99080c1120bd13973fb94ebabdf757613abc5dc551f884f6e917ac Intent Patient tissue tumor-vs-normal Organism Homo sapiens Assay bulk RNA-seq Intent defaults Active 5 active filters Page 3 of 4 · showing 101-150
Active intent defaults Tumor-normal onlyTissue or biopsy onlyHide biofluid/model systemsHuman onlyBulk RNA-seq only
Study designs tumor vs matched normal or tumor vs unmatched normal
Recommendation Recommended means a human bulk RNA-seq tissue or biopsy cohort with clear tumor-normal grouping and sufficient metadata for first-pass triage.
Search intent
Intent defaults Relax defaults

Showing one page of matching results. Use next/previous for browsing, or CSV/Markdown export for the full matching set.

101
GSE125285

Characterizing gene expression patterns in Basal Cell Carcinomas and Squamous Cell Carcinomas

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 70 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
102
GSE133039

Epigenetic footprint of hepatoblastoma defines a novel integrative molecular classification with clinical implications [RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 66 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
103
GSE148036

Lung transcriptional profiling of pulmonary tuberculosis, adenocarcinoma and sarcoidosis patients using RNA-Seq

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
104
GSE150474

Malignant melanotic Xp11 neoplasms exhibit a clinicopathological spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 51 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
105
GSE154211

RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 10 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
106
GSE164441

A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma [RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
107
GSE175492

Transcriptome analysis of normal control and miR-412-3p overexpressing in 786-0 cells

Not suitable Overall 34% Suitability 0% Metadata 85%
Case colorectal cancer Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Tissue or cell type could not be normalized.
108
GSE191334

Bulk RNA-Seq of cutaneous squamous cell carcinomas (cSCC) with paired normal controls

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
109
GSE192912

Cancer-associated Fibroblast-derived SPP1 is a Potential Target for Overcoming Sorafenib and Lenvatinib Resistance in Hepatocellular Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 19 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
110
GSE208089

Comprehensive profile and contrastive analysis of circular RNA in cervical squamous carcinoma and adenocarcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
info Treated samples may need review depending on the comparison. warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Tissue or cell type could not be normalized.
111
GSE214846

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 130 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
112
GSE223804

Changes in gene expression and mechanisms underlying activation of tumor invasion and spread at the early steps of squamous cervical carcinoma progression.

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Tissue or cell type could not be normalized.
113
GSE229705

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [bulk RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 246 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
114
GSE241466

Transcriptomic profiling of the intermediate cell carcinoma of the primary liver cancer

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 25 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
115
GSE24283

Deep transcriptional sequencing analysis of human prostate adenocarcinoma and reference samples

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v19
GEO source Trusted counts
critical Animal sample markers were detected in a human dataset. warning Disease or condition label could not be normalized.
116
GSE251942

Hight througput RNA sequencing in a cohort of HBV related HCC and healty liver samples

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 25 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
117
GSE272510

Lysine metabolism reprogramming reshapes the immune microenvironment and induces immunotherapy tolerance in liver cancer

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
118
GSE304512

Developing precision medicine for remote liver cancer patients

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 38 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
119
GSE33294

Transcriptome sequencing of human hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
120
GSE49155

Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 24 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
121
GSE58375

SMO variants explain the majority of drug resistance in basal cell carcinoma [RNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 21 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
122
GSE77314

RNA-seq of 50 paired hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 100 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
123
GSE81550

RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized.
124
GSE97214

Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 18 samples intent-aware-scoring-v19
GEO source Trusted counts
critical Animal sample markers were detected in a human dataset. warning Disease or condition label could not be normalized.
125
GSE111423

circRNA profile in hypopharyngeal cancer

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
126
GSE112083

RNA-Seq of fibrosarcoma with ESCC case

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 2 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
127
GSE124535

Gene expression profiles of 35 paired HCC and non-tumor tissues by RNA-seq data

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 70 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
128
GSE130078

A Novel LincRNA HERES Epigenetically Regulates Wnt Signaling Pathway via Interaction with EZH2 in Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 46 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
129
GSE135631

RNA-Seq data of tumors and paired adjacent tissues from 15 HCC patients

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 30 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
130
GSE141438

RNA-seq dataset for MPNST patient tissue samples

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 17 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
131
GSE145372

Whole transcriptome sequencing in human cervical adenocarcinoma and normal cervical tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
132
GSE146719

Transcriptome analysis in hepatocellular carcinoma (HCC) tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
133
GSE148389

MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3) (RNA-seq dataset)

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 160 samples intent-aware-scoring-v19
GEO source Trusted counts
info Ambiguous sample metadata was detected in 4 sample(s): GSM4467002 matched "unknown"; GSM4467003 matched "unknown"; GSM4467004 matched "unknown"; additional ambiguous samples omitted. Review these samples before inclusion or manual group assignment. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
134
GSE155800

Identification of transcriptional difference between Imatinib-sensitive and resistant patients with gastrointerstinal stromal tumor (GIST)

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
135
GSE157373

Integrative analysis of differential circular RNA and long noncoding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
136
GSE159330

Expression profiling by small RNA-seq for identifying miRNAs associated with pathological classifications in thyroid cancer.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 34 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
137
GSE159721

Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 246 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
138
GSE165595

Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations find a uniqueness in oligodendroglioma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 82 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
139
GSE166773

Next generation sequencing facilities quantitative analysis of human oropharyngeal squamous cell carcinoma, small cell carcinoma and non-cancerous tonsil tissue.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 3 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
140
GSE167573

Next generation sequencing of TFE3-translocation renal cell carcinoma and adjacent normal tissue transcriptomes

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 77 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
141
GSE184616

RNA-seq of HPV-negative Oral Squamous Cell Carcinoma Patients

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 30 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
142
GSE190079

Noncoding RNA expression profiles in five pairs of bladder cancer tumor tissues and matched adjacent non-tumor tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 10 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
143
GSE194116

Prognostic value of SPODD1 in esophageal squamous cell carcinoma: a comprehensive study based on bioinformatics and validation

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
144
GSE20116

RNA-Seq of oral squamous cell carcinomas and matched normal tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
145
GSE205512

Genome-wide methylation analysis of cerebrospinal fluid circulating tumor DNA: a new biomarker for recurrent glioblastoma [mRNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 5 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Dataset has fewer than six samples and should not be treated as a high-confidence cohort without manual review. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
146
GSE213565

Transcriptional Characterization of Early Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
147
GSE216115

Biological function and mechanism of circRNA in the occurrence and development of hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 4 warnings require review.
GEO Homo sapiens bulk RNA-seq 2 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
148
GSE216664

Gene expression profiling analysis of laryngeal cancer

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
149
GSE222421

Circ_0021350 plays an oncogene role by regulating miR-1207-3p/ PIK3R3 in glioblastoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
150
GSE228393

Gene expression in cancerous and paraneoplastic tissues of patients with head and neck squamous cell carcinoma.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v19
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.